Wave Life Sciences
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Wave Life Sciences
Wave Life Sciences Ltd. 於2012年7月23日在新加坡正式註冊成立，是一家處於臨床階段的生物技術公司，專注於充分發揮RNA藥物（亦稱為寡核苷酸）對靶向核糖核酸（RNA）治療潛力的廣泛應用，致力改變人類健康的面貌。公司所開發的PRISMTM RNA藥物平台結合多種機制與化學創新，並依托深刻的人類遺傳學洞察，實現針對罕見及常見疾病的科學突破。Wave Life Sciences擁有涵蓋RNA編輯、剪接、反義沉默及RNA干擾（RNAi）在內的多樣RNA靶向技術工具，為設計及持續打造精準對抗疾病生物學的候選藥物提供了獨特優勢。目前，公司主導的多項研發項目涵蓋罕見疾病與常見病症，包括α-1抗胰蛋白酶缺乏症（AATD）、肥胖症、杜氏肌營養不良症（DMD）及亨廷頓氏病（HD）等。欲了解更多資訊，請訪問公司官網：http://www.wavelifesciences.com。 公司地址： 7 Straits View #12-00 Marina One East Tower Singapore 018936
如何購買 Wave Life Sciences (WVE)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 WVE
透過 RockFlow App 或網頁端搜尋 WVE，輸入您想要投資的金額，然後點擊確認即可完成交易。
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.